Lieutenant Commander, 4501 X st, Radiation Oncology, Sacramento, CA 95817, USA.
Ther Adv Urol. 2012 Jun;4(3):113-24. doi: 10.1177/1756287212442977.
Around 70% of men presenting with prostate cancer will have organ-confined disease, with the majority presenting with low- or intermediate-risk prostate cancer. This article reviews the evidence supporting the current standard of care in radiation oncology for the evaluation and management of men with intermediate-risk prostate cancer. Dose escalation, hormonal therapy, combined modality therapy, and modern techniques for the delivery of radiation therapy are reviewed.
约 70%的前列腺癌患者为局限性前列腺癌,其中大多数为低危或中危前列腺癌。本文回顾了支持当前放射肿瘤学中对中危前列腺癌患者评估和管理的标准治疗方法的证据。对提高剂量、激素治疗、联合治疗模式以及放射治疗的现代技术进行了回顾。